Approval · Notice of Compliance 9556 · 2008
MYCAMINE: Notice of Compliance 9556
Issued May 21, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9556
- Date
- May 21, 2008
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYCAMINE | 02311054 | Cancelled Post Market |
Medicinal ingredients
- MICAFUNGIN SODIUM 100 MG per VIAL